UBS Group’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,087
Closed -$2K 10494
2021
Q2
$2K Buy
+2,087
New +$1.65K ﹤0.01% 9059

Other funds holding FSNB.WS

UBS Group's FSNB.WS Position: Q3 2021 in Review

UBS Group sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q3 2021, closing a stake of 2,087 shares — an estimated $2K sold.

UBS Group first reported a position in FSNB.WS in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 66 funds tracked by Wall St. Rank hold FSNB.WS as of Q3 2021.

  • UBS Group reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q3 2021 after selling out during the quarter.
  • UBS Group sold 2,087 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q3 2021, an estimated $2K.
  • UBS Group first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q2 2021 and held it in 1 quarter.
  • UBS Group's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $2K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.